Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE)

Historical Holders from Q1 2023 to Q4 2024

Symbol
APRE on Nasdaq
CUSIP
03836J201
Type / Class
Equity / Common stock, par value $0.001 per share
Shares outstanding
5.49M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
2.08M
Holdings value
$6.83M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
25
Number of buys
8
Number of sells
-4
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Nantahala Capital Management, LLC 7.3% $860K 412K Nantahala Capital Management, LLC Sep 30, 2024
Stonepine Capital Management, LLC 5.1% $599K 286K Stonepine Capital Management, LLC Dec 31, 2024
Sio Capital Management, LLC 5.04% $578K 277K Sio Capital Management, LLC Mar 31, 2025

Institutional Holders of Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q4 2.08M $6.83M +$211K $3.29 25
2024 Q3 2M $5.5M -$431K $2.75 20
2024 Q2 2.08M $8.47M +$1.87M $4.07 26
2024 Q1 1.62M $10.8M +$4.9M $6.69 21
2023 Q4 926K $4.35M +$220K $4.70 18
2023 Q3 876K $3.66M -$18.5K $4.17 20
2023 Q2 881K $2.77M +$102K $3.15 17
2023 Q1 848K $3.77M +$3.77M $4.44 16